Results 61 to 70 of about 35,525 (153)

Potential mechanisms responsible for cardioprotective effects of sodium–glucose co-transporter 2 inhibitors

Cardiovascular Diabetology, 2018
Diabetes mellitus currently affects over 350 million patients worldwide and is associated with many deaths from cardiovascular complications. Sodium–glucose co-transporter 2 (SGLT-2) inhibitors are a novel class of antidiabetic drugs with cardiovascular ...
Sarayut Lahnwong, Siriporn C. Chattipakorn, Nipon Chattipakorn   +2 more
doaj   +1 more source

Differential diagnosis and treatment of diabetes mellitus associated with Cushig’s disease

Ожирение и метаболизм, 2017
Diabetes mellitus associated with endogenic hypercortisolism is one of the most frequent symptoms of Cushing’s disease and may mask other implications.
Larisa K. Dzeranova, Ekaterina E. Bibik, Ekaterina A. Pigarova, Taras S. Panevin, Andrey Yu. Grigor'ev   +4 more
doaj   +1 more source

Euglycemia despite a sodium glucose co-transporter 2 inhibitor overdose [PDF]

World Journal of Emergency Medicine, 2022
Muhammad Akbar, Baig, Joshua, Nogar
openaire   +2 more sources

Sodium–Glucose Co-Transporter 2 Inhibitors and Acute Heart Failure [PDF]

European Journal of Heart Failure, 2020
Amy, Groenewegen, Frans H, Rutten
openaire   +2 more sources

The effect of sodium‐glucose co‐transporter 2 inhibitors on outcomes after cardiac resynchronization therapy

ESC Heart Failure
Aims The trials upon which recommendations for the use of cardiac resynchronization therapy (CRT) in heart failure used optimal medical therapy (OMT) before sodium‐glucose co‐transporter 2 inhibitors (SGLT2i).
Jonathan J.H. Bray, Marco Coronelli, Sam G.C. Scott, John A. Henry, Liam S. Couch, Mahmood Ahmad, Julian Ormerod, James Gamble, Timothy R. Betts, Andrew Lewis, Oliver J. Rider, Peregrine G. Green, Neil Herring   +12 more
doaj   +1 more source

Update on developments with SGLT2 inhibitors in the management of type 2 diabetes

Drug Design, Development and Therapy, 2014
Michael A Nauck Department of Internal Medicine, Diabeteszentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany Abstract: The importance of the kidney's role in glucose homeostasis has gained wider understanding in recent years.
Nauck MA
doaj  

Patient considerations in the management of type 2 diabetes – critical appraisal of dapagliflozin

Patient Preference and Adherence, 2014
Marissa C Salvo,1 Amie D Brooks,2 Stacey M Thacker3 1Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT, 2Department of Pharmacy Practice, St Louis College of Pharmacy, St Louis, MO, 3Department of Pharmacy Practice,
Salvo MC, Brooks AD, Thacker SM
doaj  

Cognitive Benefits of Sodium-Glucose Co-Transporters-2 Inhibitors in the Diabetic Milieu

Current Medicinal Chemistry
Abstract: Patients with diabetes are at higher risk of cognitive impairment and memory loss than the normal population. Thus, using hypoglycemic agents to improve brain function is important for diabetic patients. Sodium-glucose cotransporters-2 inhibitors (SGLT2i) are a class of therapeutic agents used in the management of diabetes that has some ...
Yaribeygi, Habib, Sathyapalan, Thozhukat, Maleki, Mina, Rizzo, Manfredi, Sahebkar, Amirhossein   +4 more
openaire   +3 more sources

Management of Heart Failure in a Resource-Limited Setting: Expert Opinion from India

Cardiology and Therapy
Heart failure poses a global health challenge affecting millions of individuals, and access to guideline-directed medical therapy is often limited. This limitation is frequently attributed to factors such as drug availability, slow adoption, clinical ...
Peeyush Jain, Santanu Guha, Soumitra Kumar, J. P. S. Sawhney, Kamal Sharma, K. P. Sureshkumar, Ashwani Mehta, Rajnish Dhediya, Kumar Gaurav, Rajan Mittal, Bhavesh Kotak   +10 more
doaj   +1 more source

Sodium glucose co transporter 2 inhibitors and Ramadan: Another string to the bow

Indian Journal of Endocrinology and Metabolism, 2014
Jayant Kelwade, Bipin Kumar Sethi, Ayesha Vaseem, V Sri Nagesh   +3 more
doaj   +1 more source